Opportunities in immunotherapy of ovarian cancer. - Wikidata - awgldk - TriplyDB

Opportunities in immunotherapy of ovarian cancer.

Opportunities in immunotherapy of ovarian cancer.

http://www.wikidata.org/entity/Q36855245

about

Molecular Characterization of Epithelial Ovarian Cancer: Implications for Diagnosis and Treatment A brief review of the management of platinum-resistant-platinum-refractory ovarian cancer.

P2860

Q28066904-69ED7F43-F875-4EE4-A369-A7086C2CDBCC Q39263789-51EDE82E-79F8-444B-9AB3-020DEC68A860

P2860

Opportunities in immunotherapy of ovarian cancer.

http://www.wikidata.org/entity/Q36855245

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Opportunities in immunotherapy of ovarian cancer.

@en

type

label

Opportunities in immunotherapy of ovarian cancer.

@en

prefLabel

Opportunities in immunotherapy of ovarian cancer.

@en

P1433

Q36855245-63C9C208-AF99-4D9F-8734-D9794ED80CB3

P1476

Q36855245-4A657395-CD25-4883-8C5F-80E3E1AFD98E

P2093

Q36855245-1524A2CB-75EF-4A03-B471-9F9CB110DBA1

Q36855245-77427E50-8871-44DC-8B6D-AC165176AA09

P2860

Q36855245-00574B07-DA4F-4C9C-B90E-07AB0DD51E6C

Q36855245-05611FA7-1B86-4C6A-9E0D-7115E64A97C4

Q36855245-08590AA7-26F6-4DD1-8960-2550B245B850

Q36855245-08B3C8BB-3B37-487C-B9CD-C6621279B2BC

Q36855245-0CFC1513-0A8D-43FF-AAD4-3E8068A26F44

Q36855245-0FCF0838-F9D7-406D-A896-E8772EC1E13B

Q36855245-1A76F3DC-D842-4354-B32B-68FA4B71BA9E

Q36855245-1C711BBC-F407-47E3-8EDE-67E6FEC4B715

Q36855245-1DAE869E-123B-4178-83B5-5C225C26E91D

Q36855245-2A8BA3B9-FE1A-4F6B-BF93-40C75D70AAC2

P304

Q36855245-6C12DD16-1D18-46AC-8D77-372440EB1DB9

P31

Q36855245-5ED240C8-14A5-410C-AE41-532D393DC0DE

Q36855245-c1530332-d2ec-4f31-b941-403109e31dd7

P356

Q36855245-B88C41BB-23E0-4562-9D32-55D897527709

P478

Q36855245-FB23F3F5-D7D2-4589-B0FE-8E86DA264B39

P50

Q36855245-13C84AC3-7E03-4365-9925-9FAAC47014E7

P577

Q36855245-C7118B2E-BA84-42F2-AD02-1041735CA893

P698

Q36855245-FB506794-0E12-4853-98F2-03F9B61DF111

P921

Q36855245-B814EDDD-66F3-4A2D-869D-BFDA5CE3A2DD

Q36855245-C6C5E42D-B3B0-4278-AD2B-7709A3C0B888

P932

Q36855245-0979130D-8D89-4E5A-B0B8-F2EE90706307

P356

P1433

Annals of Oncology

P1476

Opportunities in immunotherapy of ovarian cancer

@en

P2093

J Tanyi

http://www.w3.org/2001/XMLSchema#string

L E Kandalaft

http://www.w3.org/2001/XMLSchema#string

P2860

Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade.

Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8+ T cells

Cancer immunotherapy: moving beyond current vaccines

Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia

Human T regulatory cell therapy: take a billion or so and call me in the morning

Programmed cell death 1 ligand 1 and tumor-infiltrating CD8+ T lymphocytes are prognostic factors of human ovarian cancer

Emerging immunotherapies in ovarian cancer

Harnessing the potential of radiation-induced immune modulation for cancer therapy

Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer

Immune checkpoint blockade: a common denominator approach to cancer therapy

P304

i11-i15

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/ANNONC/MDW084

http://www.w3.org/2001/XMLSchema#string

P478

27 Suppl 1

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27141063

http://www.w3.org/2001/XMLSchema#string

P921

P932

4852275

http://www.w3.org/2001/XMLSchema#string